Search Results - "PANCHAL, Seema"

Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial by Bombard, Yvonne, Clausen, Marc, Shickh, Salma, Mighton, Chloe, Casalino, Selina, Kim, Theresa H.M., Muir, Sarah M., Carlsson, Lindsay, Baxter, Nancy, Scheer, Adena, Elser, Christine, Eisen, Andrea, Panchal, Seema, Graham, Tracy, Aronson, Melyssa, Piccinin, Carolyn, Mancuso, Talia, Semotiuk, Kara, Evans, Michael, Carroll, June C., Offit, Kenneth, Robson, Mark, Hamilton, Jada G., Glogowski, Emily, Schrader, Kasmintan, Kim, Raymond H., Lerner-Ellis, Jordan, Thorpe, Kevin E., Laupacis, Andreas, Bombard, Yvonne, Armel, Susan, Aronson, Melyssa, Bayoumi, Ahmed, Bond, Ken, Caulfield, Timothy, Clausen, Marc, Clifford, Tammy, Cohn, Iris, Dhalla, Irfan, Earle, Craig C., Elser, Christine, Isaranuwatchai, Wanrudee, Kastner, Monika, Kim, Raymond H., Mujoomdar, Michelle, Robson, Mark E., Scheer, Adena, Scherer, Stephen W., Schrader, Kasmintan, Sullivan, Terrence, Thorpe, Kevin E.

“…To evaluate the effectiveness of the Genomics ADvISER (www.genomicsadviser.com) decision aid (DA) for selection of secondary findings (SF), compared with…”
Get full text

The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care by Shickh, Salma, Rafferty, Sara A., Clausen, Marc, Kodida, Rita, Mighton, Chloe, Panchal, Seema, Lorentz, Justin, Ward, Thomas, Watkins, Nicholas, Elser, Christine, Eisen, Andrea, Carroll, June C., Glogowski, Emily, Schrader, Kasmintan A., Lerner-Ellis, Jordan, Kim, Raymond H., Chitayat, David, Shuman, Cheryl, Bombard, Yvonne, Bombard, Yvonne, Armel, Susan, Aronson, Melyssa, Baxter, Nancy, Bond, Kenneth, Capo-Chichi, José-Mario, Caulfield, Timothy, Clifford, Tammy, Cohn, Iris, Dhalla, Irfan, Earle, Craig C., Evans, Mike, Graham, Tracy, Hamilton, Jada G., Isaranuwatchai, Wanrudee, Kastner, Monika, Laupacis, Andreas, Morel, Chantal F., Mujoomdar, Michelle, Offit, Kenneth, Robson, Mark E., Scheer, Adena, Scherer, Stephen W., Sullivan, Terrence, Thorpe, Kevin E.

“…Alternative models of genetic counseling are needed to meet the rising demand for genomic sequencing. Digital tools have been proposed as a method to augment…”
Get full text

Selecting a BRCA risk assessment model for use in a familial cancer clinic by Panchal, Seema M, Ennis, Marguerite, Canon, Sandra, Bordeleau, Louise J

“…Risk models are used to calculate the likelihood of carrying a BRCA1 or BRCA2 mutation. We evaluated the performances of currently-used risk models among…”
Get full text

Quality of life drives patients' preferences for secondary findings from genomic sequencing by Mighton, Chloe, Carlsson, Lindsay, Clausen, Marc, Casalino, Selina, Shickh, Salma, McCuaig, Laura, Joshi, Esha, Panchal, Seema, Semotiuk, Kara, Ott, Karen, Elser, Christine, Eisen, Andrea, Kim, Raymond H, Lerner-Ellis, Jordan, Carroll, June C, Glogowski, Emily, Schrader, Kasmintan, Bombard, Yvonne

“…There is growing impetus to include measures of personal utility, the nonmedical value of information, in addition to clinical utility in health technology…”
Get full text

Incidental findings from cancer next generation sequencing panels by Maani, Nika, Panabaker, Karen, McCuaig, Jeanna M., Buckley, Kathleen, Semotiuk, Kara, Farncombe, Kirsten M., Ainsworth, Peter, Panchal, Seema, Sadikovic, Bekim, Armel, Susan Randall, Lin, Hanxin, Kim, Raymond H.

“…Next-generation sequencing (NGS) technologies have facilitated multi-gene panel (MGP) testing to detect germline DNA variants in hereditary cancer patients…”
Get full text

Development of patient "profiles" to tailor counseling for incidental genomic sequencing results by Mighton, Chloe, Carlsson, Lindsay, Clausen, Marc, Casalino, Selina, Shickh, Salma, McCuaig, Laura, Joshi, Esha, Panchal, Seema, Graham, Tracy, Aronson, Melyssa, Piccinin, Carolyn, Winter-Paquette, Laura, Semotiuk, Kara, Lorentz, Justin, Mancuso, Talia, Ott, Karen, Silberman, Yael, Elser, Christine, Eisen, Andrea, Kim, Raymond H, Lerner-Ellis, Jordan, Carroll, June C, Glogowski, Emily, Schrader, Kasmintan, Bombard, Yvonne

“…Guidelines recommend that providers engage patients in shared decision-making about receiving incidental results (IR) prior to genomic sequencing (GS), but…”
Get full text

Predictors of mammographic density among women with a strong family history of breast cancer by Moran, Olivia, Eisen, Andrea, Demsky, Rochelle, Blackmore, Kristina, Knight, Julia A, Panchal, Seema, Ginsburg, Ophira, Zbuk, Kevin, Yaffe, Martin, Metcalfe, Kelly A, Narod, Steven A, Kotsopoulos, Joanne

“…Mammographic density is one of the strongest risk factors for breast cancer. In the general population, mammographic density can be modified by various…”
Get full text

Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery by Shickh, Salma, Hirjikaka, Daena, Clausen, Marc, Kodida, Rita, Mighton, Chloe, Reble, Emma, Sam, Jordan, Panchal, Seema, Aronson, Melyssa, Graham, Tracy, Armel, Susan Randall, Glogowski, Emily, Elser, Christine, Eisen, Andrea, Carroll, June C, Shuman, Cheryl, Seto, Emily, Baxter, Nancy N, Scheer, Adena, Shastri-Estrada, Serena, Feldman, Geoff, Thorpe, Kevin E, Schrader, Kasmintan A, Lerner-Ellis, Jordan, Kim, Raymond H, Faghfoury, Hanna, Bombard, Yvonne

“…IntroductionThe high demand for genetic tests and limited supply of genetics professionals has created a need for alternative service delivery models. Digital…”
Get full text

P538: Curious but cautious: Patients’ preferences for all types of clinically actionable genomic incidental results by Shickh, Salma, Kodida, Rita, Mighton, Chloe, Clausen, Marc, Reble, Emma, Sam, Jordan, Grewal, Sonya, Panchal, Seema, Aronson, Melyssa, Armel, Susan, Graham, Tracy, Elser, Christine, Eisen, Andrea, Carroll, June, Glogowski, Emily, Schrader, Kasmintan, Thorpe, Kevin, Lerner-Ellis, Jordan, Kim, Raymond, Bombard, Yvonne

Get full text

P555: Clinical utility returning of all types of medically relevant genomic sequencing findings: An observational study by Mighton, Chloe, Kodida, Rita, Shickh, Salma, Clausen, Marc, Reble, Emma, Sam, Jordan, Grewal, Sonya, Panchal, Seema, Aronson, Melyssa, Armel, Susan, Graham, Tracy, Forster, Nicole, Capo-Chichi, Jose-Mario, Greenfeld, Elena, Noor, Abdul, Cohn, Iris, Morel, Chantal, Elser, Christine, Eisen, Andrea, Carroll, June, Glogowski, Emily, Schrader, Kasmintan, Chan, Kelvin, Thorpe, Kevin, Lerner-Ellis, Jordan, Kim, Raymond, Bombard, Yvonne

Get full text

P523: Returning all clinically relevant findings from genomic sequencing: Preliminary results from the incidental genomics RCT by Bombard, Yvonne, Mighton, Chloe, Shickh, Salma, Clausen, Marc, Kodida, Rita, Reble, Emma, Sam, Jordan, Grewal, Sonya, Panchal, Seema, Aronson, Melyssa, Armel, Susan, Graham, Tracy, Forster, Nicole, Capo-Chichi, Jose-Mario, Greenfeld, Elena, Noor, Abdul, Cohn, Iris, Morel, Chantal, Elser, Christine, Eisen, Andrea, Carroll, June, Glogowski, Emily, Schrader, Kasmintan, Lerner-Ellis, Jordan, Kim, Raymond, Thorpe, Kevin

Get full text

P409: Clinical utility of genomic sequencing for hereditary cancer syndromes: An observational chart review by Shickh, Salma, Mighton, Chloe, Clausen, Marc, Kodida, Rita, Sam, Jordan, Hirjikaka, Daena, Reble, Emma, Graham, Tracy, Panchal, Seema, Eisen, Andrea, Elser, Christine, Schrader, Kasmintan, Baxter, Nancy N., Laupacis, Andreas, Lerner-Ellis, Jordan, Kim, Raymond, Bombard, Yvonne

Get full text

A Review of Genetic Counseling for Charcot Marie Tooth Disease (CMT) by Siskind, Carly E., Panchal, Seema, Smith, Corrine O., Feely, Shawna M. E., Dalton, Joline C., Schindler, Alice B., Krajewski, Karen M.

“…Charcot Marie Tooth disease (CMT) encompasses the inherited peripheral neuropathies. While four genes have been found to cause over 90 % of genetically…”
Get full text

Changing My Perspective: What My Husband’s Cancer Taught Me About Being a Genetic Counselor by Panchal, Seema

“…The author describes her family experience with cancer. Part of a special journal issue focused on 'defining moments' in genetic counselor professional…”
Get full text

An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer by Piccinin, Carolyn, Panchal, Seema, Watkins, Nicholas, Kim, Raymond H

“…Introduction: In the past 5 years, multi-gene panels have replaced the practice of BRCA1 and BRCA2 genetic testing in cases of suspected inherited breast…”
Get full text

Recontact to return new or updated PALB2 genetic results in the clinical laboratory setting by Panchal, Seema, Mahajan, Radhika, Aujla, Navneet, McKay, Paul, Casalino, Selina, Di Gioacchino, Vanessa, Charames, George S, Lefebvre, Maude, Metcalfe, Kelly A, Akbari, Mohammad Reza, McCuaig, Jeanna Marie, Lerner-Ellis, Jordan

“…The purpose of this study was to recontact individuals with clinically actionable test results identified through a retrospective research study and to provide…”
Get more information

Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis by Metcalfe, Kelly, Huzarski, Tomasz, Gronwald, Jacek, Kotsopoulos, Joanne, Kim, Raymond, Moller, Pal, Pal, Tuya, Aeilts, Amber, Eisen, Andrea, Karlan, Beth, Bordeleau, Louise, Tung, Nadine, Olopade, Olufunmilayo, Zakalik, Dana, Singer, Christian F., Foulkes, William, Couch, Fergus, Neuhausen, Susan L., Eng, Charis, Sun, Ping, Lubinski, Jan, Narod, Steven A.

“…Background Risk-reducing mastectomy (RRM) is offered to women with a BRCA1 or BRCA2 pathogenic variant, however, there are limited data on the impact on breast…”
Get full text

Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation by Kotsopoulos, Joanne, Gronwald, Jacek, Huzarski, Tomasz, Aeilts, Amber, Randall Armel, Susan, Karlan, Beth, Singer, Christian F., Eisen, Andrea, Tung, Nadine, Olopade, Olufunmilayo, Bordeleau, Louise, Eng, Charis, Foulkes, William D., Neuhausen, Susan L., Cullinane, Carey A., Pal, Tuya, Fruscio, Robert, Lubinski, Jan, Metcalfe, Kelly, Sun, Ping, Narod, Steven A.

“…Purpose Chemoprevention with a selective estrogen receptor modulator (tamoxifen or raloxifene) is a non-surgical option offered to high-risk women to reduce…”
Get full text

Opportunistic genomic screening has clinical utility: An interventional cohort study by Mighton, Chloe, Kodida, Rita, Shickh, Salma, Clausen, Marc, Reble, Emma, Sam, Jordan, Grewal, Sonya, Hirjikaka, Daena, Panchal, Seema, Piccinin, Carolyn, Aronson, Melyssa, Ward, Thomas, Armel, Susan Randall, Hofstedter, Renee, Graham, Tracy, Mancuso, Talia, Forster, Nicole, Capo-Chichi, José-Mario, Greenfeld, Elena, Noor, Abdul, Cohn, Iris, Morel, Chantal F., Elser, Christine, Eisen, Andrea, Carroll, June C., Glogowksi, Emily, Schrader, Kasmintan A., Chan, Kelvin K.W., Thorpe, Kevin E., Lerner-Ellis, Jordan, Kim, Raymond H., Bombard, Yvonne

“…Practice is shifting toward genome-first approaches, such as opportunistic screening for secondary findings (SFs). Analysis of SFs could be extended beyond…”
Get full text

An evaluation of memory and attention in BRCA mutation carriers using an online cognitive assessment tool by Kotsopoulos, Joanne, Kim, Shana J., Armel, Susan, Bordeleau, Louise, Foulkes, William D., McKinnon, Wendy, Panchal, Seema, Cohen, Stephanie A., Sun, Sophie, Sun, Ping, McKetton, Larissa, Troyer, Angela K., Narod, Steven A.

“…Background The objective of this study was to evaluate the impact of various surgical, hormonal, and lifestyle factors on memory and attention in women with a…”
Get full text